abstract |
Stabilized pharmaceutical compositions comprising substantially monomeric interferon-beta (IFN-β) and methods useful in their preparation are provided. The compositions comprise the IFN-β solubilized in a low-ionic-strength formulation that maintains the composition at a pH of about 5.0. methods for preparing these compositions, and for increasing solubility of IFN-β in pharmaceutical compositions, are provided. |